Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A

Phase 2

Recruiting

• Conditions: Charcot-Marie-Tooth disease type 1A; CMT1A; G600

• Registration Number: JPRN-jRCTs031190109
• Lead Sponsor: SHIOHAMA TADASHI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-03
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

1. Children under 18 years of age with confirmed PMP22 duplication in genetic testing.
2. Normal data in blood examination.
3. Normal data in urinary analysis.
4. Written informed consent from the patient, or parents in case of children.

Exclusion Criteria

1. The patient has already taken daily vitamin treatment.
2. When the investigator or the investigator considers it inappropriate to conduct this study safely.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CMT score

Secondary Outcome Measures

Name	Time	Method
Electrophysiological examination, Six minutes walking distance